Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00000178 · ClinicalTrials.gov registry record · Phase 3
Multicenter Trial of Prednisone in Alzheimer's Disease
A Phase 3 study, sponsored by National Institute on Aging (NIA).
- Completed
- Registry status
- Phase 3
- Development phase
NCT00000178: Completed Phase 3 study, sponsored by National Institute on Aging (NIA).
NCT00000178 is a Phase 3 study that has completed, run by National Institute on Aging (NIA). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00000178, a Phase 3 study, has completed, sponsored by National Institute on Aging (NIA).
- COMPLETED
- Registry status
- Phase 3
- Development phase
Study Summary
This is a randomized placebo controlled, double blind study. Patients who meet eligibility criteria and decide to participate in the study will be randomly assigned to receive either drug treatment or a placebo. Neither the patients nor the participating investigators will know who is receiving the drugs and who is receiving the placebo. Participation involves 15 outpatient clinic visits over a 68 week period. Patients take study medication at varying doses (the maximum dose is 20 mg daily), along with calcium and vitamin supplements.
Interventions
- DRUG Prednisone
Trial Details
| Field | Value |
|---|---|
| Phase | Phase 3 |
What the finished NCT00000178 record still lists
NCT00000178 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 1 intervention - of which Prednisone is the first listed.
NCT00000178 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00000178 about?
NCT00000178 is a clinical study titled "Multicenter Trial of Prednisone in Alzheimer's Disease". This is a randomized placebo controlled, double blind study. Patients who meet eligibility criteria and decide to participate in the study will be randomly assigned to receive either drug treatment or a placebo. Neither the patients nor the participating investigators will know who is receiving the ...
What is the current status of trial NCT00000178?
This trial is currently completed. It is a Phase 3 study.
What interventions are being tested in trial NCT00000178?
The interventions under investigation include: Prednisone (DRUG).
Who is sponsoring clinical trial NCT00000178?
This trial is sponsored by National Institute on Aging (NIA), which has 131 total clinical trials registered on ClinicalTrials.gov.